Albronic 70 Tablet contains Alendronic Acid, a bisphosphonate widely prescribed for the treatment and prevention of osteoporosis, particularly in postmenopausal women and men at high risk of fractures. Osteoporosis is characterized by bone weakening, making bones prone to fractures, especially in the hip, spine, and wrist. Alendronic Acid helps restore bone density by reducing osteoclast activity, the cells responsible for bone resorption, leading to stronger bones and a lower risk of fractures.
Albronic 70 Tablet is designed for once-weekly dosing, offering convenience and adherence to therapy. Patients must take the tablet with plain water on an empty stomach, preferably in the morning, at least 30 minutes before any food, beverage, or other medications. Remaining upright for at least 30 minutes after taking the dose minimizes the risk of esophageal irritation and enhances absorption.
In addition to osteoporosis, Albronic 70 may be indicated for treating Paget’s disease of bone, a condition where abnormal bone remodeling occurs, leading to weakened and deformed bones. Supplementation with calcium and vitamin D is often recommended alongside Albronic 70 for optimal results.